2013 American Transplant Congress
Tuberculosis in Kidney Transplant – 10 Years Experience
Nephrology Division, Hospital do Rim e Hipertensão, Sao Paulo, Brazil
Introduction: Tuberculosis infection (TB) increases morbidity and mortality after kidney transplantation (TX) and poses diagnostic and therapeutic challenges. The incidence of TB among solid organ…2013 American Transplant Congress
Influence of Recipient Cytochrome P450 3A5 Polymorphism on the Metabolism of Advagraf Administered De Novo after Renal Transplantation
Advagraf (Adv), a prolonged release formulation of tacrolimus (tac), allows once-a-day administration and improves medication adherence.Patients (pts) possessing at least one CYP3A5*1 allele have an…2013 American Transplant Congress
HLA Antibody Increase Associated with Cardiac Surgery
Increases in titer or de novo production of HLA antibody are potential sequelae of pregnancy, transfusion, or transplantation. It has also been reported that pro-inflammatory…2013 American Transplant Congress
Age and Antimetabolites: Appropriate Candidate Selection Drives Success
Pharmacy, Barnes-Jewish Hospital, St. Louis, MO; Medicine, Washington University, St. Louis, MO
Background:Early studies comparing mycophenolate (MMF) to azathioprine (AZA) post-renal transplant demonstrated superiority of MMF over AZA for the prevention of acute rejection (AR), with no…2013 American Transplant Congress
Utility of Serial Allograft Biopsies (AGBx) during Delayed Graft Function (DGF) in Renal Transplantation, The
Renal Transplant Center, Henry Ford Hospital, Detroit, MI
Background: DGF complicates approximately 30% of deceased donor (DD) kidney transplants and rarely also occurs following live donor (LD) kidney transplants (KTX). KTX in DGF…2013 American Transplant Congress
Using Non-Invasive, Real-Time Imaging Technology To Assess the Status of Donor Kidneys
Purpose. The extent of acute tubular necrosis (ATN) in renal tubules may provide valuable prognostic data regarding post-transplant renal function of donor kidneys. We used…2013 American Transplant Congress
Multicenter Evaluation of Efficacy and Safety of Valganciclovir 450 mg/day vs. 900 mg/day for Prevention of Cytomegalovirus Disease in Donor and Recipient Positive (D+/R+) Renal Transplant Recipients
Multicenter CMV Pharmacists Collaborative Study Group, Boston
The cytomegalovirus (CMV) donor-positive/recipient-positive (D+/R+) population represents the largest proportion of renal transplant recipients (RTR). Current practice guidelines on the prevention of CMV recommend antiviral…2013 American Transplant Congress
Change of Single-Kidney Glomerular Filtration Rate in Kidney Donors after Kidney Donation, The
Background: It is well known that remaining nephrons after loss of renal tissue showed compensatory hyperfiltration in chronic kidney disease. But in healthy populations without…2013 American Transplant Congress
Nutraceuticals Extenuate Kidney Ischemia/Reperfusion Injury in Rats Via HO-1 Induction
Background: The induceable Hemeoxygenase-1 (HO-1) is the rate limiting step in the conversion of heme into biliverdin, carbon monoxide (CO) and free iron (Fe2+). Up-regulation…2013 American Transplant Congress
Flow Crossmatching for Renal Transplantation in the Virtual Crossmatch Era: Fifty Shades of Grey
HLA Laboratory and the Transplant Center, Lehigh Valley Health Network, Allentown, PA
Every transplant team wants a definitive answer for the compatibility of a potential recipient with a specific donor. The Mean Equivalent Standard Fluorescence is a…
- « Previous Page
- 1
- …
- 142
- 143
- 144
- 145
- 146
- …
- 178
- Next Page »